The microbiota-gut-brain axis in functional gastrointestinal disorders

References

• Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130:1377 - 90; http://dx.doi.org/10.1053/j.gastro.2006.03.008; PMID: 16678553
   PubMed Web of Science ®Google Scholar
• D’Amato M. Genes and functional GI disorders: from casual to causal relationship. Neurogastroenterol Motil 2013; 25:638 - 49; http://dx.doi.org/10.1111/nmo.12173; PMID: 23826979
   PubMed Web of Science ®Google Scholar
• Drossman DA. Abuse, trauma, and GI illness: is there a link?. Am J Gastroenterol 2011; 106:14 - 25; http://dx.doi.org/10.1038/ajg.2010.453; PMID: 21139573
   PubMed Web of Science ®Google Scholar
• Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, Creed F. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130:1447 - 58; http://dx.doi.org/10.1053/j.gastro.2005.11.057; PMID: 16678558
   PubMed Web of Science ®Google Scholar
• Geeraerts B, Van Oudenhove L, Fischler B, Vandenberghe J, Caenepeel P, Janssens J, Tack J. Influence of abuse history on gastric sensorimotor function in functional dyspepsia. Neurogastroenterol Motil 2009; 21:33 - 41; http://dx.doi.org/10.1111/j.1365-2982.2008.01178.x; PMID: 18694440
   PubMed Web of Science ®Google Scholar
• Villarreal AA, Aberger FJ, Benrud R, Gundrum JD. Use of broad-spectrum antibiotics and the development of irritable bowel syndrome. WMJ 2012; 111:17 - 20; PMID: 22533211
   PubMedGoogle Scholar
• Grundy D, Al-Chaer ED, Aziz Q, Collins SM, Ke M, Taché Y, Wood JD. Fundamentals of neurogastroenterology: basic science. Gastroenterology 2006; 130:1391 - 411; http://dx.doi.org/10.1053/j.gastro.2005.11.060; PMID: 16678554
   PubMed Web of Science ®Google Scholar
• Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130:1480 - 91; http://dx.doi.org/10.1053/j.gastro.2005.11.061; PMID: 16678561
   PubMed Web of Science ®Google Scholar
• Dang J, Ardila-Hani A, Amichai MM, Chua K, Pimentel M. Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III. Neurogastroenterol Motil 2012; 24:853 - e397; http://dx.doi.org/10.1111/j.1365-2982.2012.01943.x; PMID: 22632582
   PubMed Web of Science ®Google Scholar
• Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. The Rome III criteria for the diagnosis of functional dyspepsia in secondary care are not superior to previous definitions. Gastroenterology 2014; 146:932 - 40, quiz e14-5; http://dx.doi.org/10.1053/j.gastro.2014.01.014; PMID: 24417817
   PubMed Web of Science ®Google Scholar
• Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria. Aliment Pharmacol Ther 2014; 39:312 - 21; http://dx.doi.org/10.1111/apt.12573; PMID: 24308816
   PubMed Web of Science ®Google Scholar
• Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013; 145:1262 - 70, e1; http://dx.doi.org/10.1053/j.gastro.2013.08.048; PMID: 23994201
   PubMed Web of Science ®Google Scholar
• Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466 - 79; http://dx.doi.org/10.1053/j.gastro.2005.11.059; PMID: 16678560
   PubMed Web of Science ®Google Scholar
• Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep 2009; 11:265 - 9; http://dx.doi.org/10.1007/s11894-009-0039-x; PMID: 19615301
   PubMedGoogle Scholar
• Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, Delvaux M, Drossman DA, Foxx-Orenstein AE, Guarner F, et al. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol 2012; 46:356 - 66; http://dx.doi.org/10.1097/MCG.0b013e318247157c; PMID: 22499071
   PubMed Web of Science ®Google Scholar
• Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002; 97:2290 - 9; http://dx.doi.org/10.1111/j.1572-0241.2002.05783.x; PMID: 12358247
   PubMed Web of Science ®Google Scholar
• Drossman DA, Chang L, Bellamy N, Gallo-Torres HE, Lembo A, Mearin F, Norton NJ, Whorwell P. Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol 2011; 106:1749 - 59, quiz 1760; http://dx.doi.org/10.1038/ajg.2011.201; PMID: 21747417
   PubMed Web of Science ®Google Scholar
• Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol 2012; 107:991 - 1000; http://dx.doi.org/10.1038/ajg.2012.131; PMID: 22613905
   PubMed Web of Science ®Google Scholar
• Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?. Aliment Pharmacol Ther 2010; 32:738 - 55; http://dx.doi.org/10.1111/j.1365-2036.2010.04409.x; PMID: 20662786
   PubMed Web of Science ®Google Scholar
• Oustamanolakis P, Tack J. Dyspepsia: organic versus functional. J Clin Gastroenterol 2012; 46:175 - 90; http://dx.doi.org/10.1097/MCG.0b013e318241b335; PMID: 22327302
   PubMed Web of Science ®Google Scholar
• Aro P, Talley NJ, Agréus L, Johansson SE, Bolling-Sternevald E, Storskrubb T, Ronkainen J. Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther 2011; 33:1215 - 24; http://dx.doi.org/10.1111/j.1365-2036.2011.04640.x; PMID: 21443537
   PubMed Web of Science ®Google Scholar
• Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98:783 - 8; http://dx.doi.org/10.1111/j.1572-0241.2003.07389.x; PMID: 12738456
   PubMed Web of Science ®Google Scholar
• Tack J, Janssen P. Gastroduodenal motility. Curr Opin Gastroenterol 2010; 26:647 - 55; http://dx.doi.org/10.1097/MOG.0b013e32833ece1e; PMID: 20838344
   PubMed Web of Science ®Google Scholar
• Van Oudenhove L, Aziz Q. The role of psychosocial factors and psychiatric disorders in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10:158 - 67; http://dx.doi.org/10.1038/nrgastro.2013.10; PMID: 23358396
   PubMed Web of Science ®Google Scholar
• Wu JC. Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management. J Neurogastroenterol Motil 2012; 18:13 - 8; http://dx.doi.org/10.5056/jnm.2012.18.1.13; PMID: 22323984
   PubMed Web of Science ®Google Scholar
• Clauwaert N, Jones MP, Holvoet L, Vandenberghe J, Vos R, Tack J, Van Oudenhove L. Associations between gastric sensorimotor function, depression, somatization, and symptom-based subgroups in functional gastroduodenal disorders: are all symptoms equal?. Neurogastroenterol Motil 2012; 24:1088 - e565; http://dx.doi.org/10.1111/j.1365-2982.2012.01985.x; PMID: 22816492
   PubMed Web of Science ®Google Scholar
• Kindt S, Van Oudenhove L, Mispelon L, Caenepeel P, Arts J, Tack J. Longitudinal and cross-sectional factors associated with long-term clinical course in functional dyspepsia: a 5-year follow-up study. Am J Gastroenterol 2011; 106:340 - 8; http://dx.doi.org/10.1038/ajg.2010.406; PMID: 20978482
   PubMed Web of Science ®Google Scholar
• Tse AW, Lai LH, Lee CC, Tsoi KK, Wong VW, Chan Y, Sung JJ, Chan FK, Wu JC. Validation of Self-administrated Questionnaire for Psychiatric Disorders in Patients with Functional Dyspepsia. J Neurogastroenterol Motil 2010; 16:52 - 60; http://dx.doi.org/10.5056/jnm.2010.16.1.52; PMID: 20535327
   PubMedGoogle Scholar
• Van Oudenhove L, Vandenberghe J, Geeraerts B, Vos R, Persoons P, Fischler B, Demyttenaere K, Tack J. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation?. Gut 2008; 57:1666 - 73; http://dx.doi.org/10.1136/gut.2008.158162; PMID: 18625692
   PubMed Web of Science ®Google Scholar
• Karling P, Danielsson A, Adolfsson R, Norrback KF. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. Neurogastroenterol Motil 2007; 19:896 - 904; http://dx.doi.org/10.1111/j.1365-2982.2007.00967.x; PMID: 17973640
   PubMed Web of Science ®Google Scholar
• Locke GR 3rd, Weaver AL, Melton LJ 3rd, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004; 99:350 - 7; http://dx.doi.org/10.1111/j.1572-0241.2004.04043.x; PMID: 15046228
   PubMed Web of Science ®Google Scholar
• Lydiard RB, Fossey MD, Marsh W, Ballenger JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics 1993; 34:229 - 34; http://dx.doi.org/10.1016/S0033-3182(93)71884-8; PMID: 8493304
   PubMed Web of Science ®Google Scholar
• Talley NJ, Fung LH, Gilligan IJ, McNeil D, Piper DW. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology 1986; 90:886 - 92; PMID: 3949118
   PubMed Web of Science ®Google Scholar
• Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 2012; 61:1284 - 90; http://dx.doi.org/10.1136/gutjnl-2011-300474; PMID: 22234979
   PubMed Web of Science ®Google Scholar
• Stasi C, Rosselli M, Bellini M, Laffi G, Milani S. Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol 2012; 47:1177 - 85; http://dx.doi.org/10.1007/s00535-012-0627-7; PMID: 22766747
   PubMed Web of Science ®Google Scholar
• Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000; 47:861 - 9; http://dx.doi.org/10.1136/gut.47.6.861; PMID: 11076888
   PubMed Web of Science ®Google Scholar
• Joëls M. Impact of glucocorticoids on brain function: relevance for mood disorders. Psychoneuroendocrinology 2011; 36:406 - 14; http://dx.doi.org/10.1016/j.psyneuen.2010.03.004; PMID: 20382481
   PubMed Web of Science ®Google Scholar
• Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994; 19:313 - 33; http://dx.doi.org/10.1016/0306-4530(94)90013-2; PMID: 8047637
   PubMed Web of Science ®Google Scholar
• Ehlert U, Nater UM, Böhmelt A. High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders. J Psychosom Res 2005; 59:7 - 10; http://dx.doi.org/10.1016/j.jpsychores.2005.03.005; PMID: 16126090
   PubMed Web of Science ®Google Scholar
• Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD, et al. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2009; 21:149 - 59; http://dx.doi.org/10.1111/j.1365-2982.2008.01171.x; PMID: 18684212
   PubMed Web of Science ®Google Scholar
• Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005; 54:1481 - 91; http://dx.doi.org/10.1136/gut.2005.064261; PMID: 16162953
   PubMed Web of Science ®Google Scholar
• Taché Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007; 117:33 - 40; http://dx.doi.org/10.1172/JCI30085; PMID: 17200704
   PubMed Web of Science ®Google Scholar
• De la Roca-Chiapas JM, Solís-Ortiz S, Fajardo-Araujo M, Sosa M, Córdova-Fraga T, Rosa-Zarate A, JM DlR-C. Stress profile, coping style, anxiety, depression, and gastric emptying as predictors of functional dyspepsia: a case-control study. J Psychosom Res 2010; 68:73 - 81; http://dx.doi.org/10.1016/j.jpsychores.2009.05.013; PMID: 20004303
   PubMed Web of Science ®Google Scholar
• Saunders PR, Santos J, Hanssen NP, Yates D, Groot JA, Perdue MH. Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig Dis Sci 2002; 47:208 - 15; http://dx.doi.org/10.1023/A:1013204612762; PMID: 11852879
   PubMed Web of Science ®Google Scholar
• Bradesi S, Schwetz I, Ennes HS, Lamy CM, Ohning G, Fanselow M, Pothoulakis C, McRoberts JA, Mayer EA. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol 2005; 289:G42 - 53; http://dx.doi.org/10.1152/ajpgi.00500.2004; PMID: 15746211
   PubMedGoogle Scholar
• Collins SM. Stress and the Gastrointestinal Tract IV. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance. Am J Physiol Gastrointest Liver Physiol 2001; 280:G315 - 8; PMID: 11171612
   PubMed Web of Science ®Google Scholar
• Bravo JA, Dinan TG, Cryan JF. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int J Neuropsychopharmacol 2011; 14:666 - 83; http://dx.doi.org/10.1017/S1461145710000994; PMID: 20860876
   PubMed Web of Science ®Google Scholar
• Park AJ, Collins J, Blennerhassett PA, Ghia JE, Verdu EF, Bercik P, Collins SM. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil 2013; 25:733 - e575; http://dx.doi.org/10.1111/nmo.12153; PMID: 23773726
   PubMed Web of Science ®Google Scholar
• Martinez V, Taché Y. CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des 2006; 12:4071 - 88; http://dx.doi.org/10.2174/138161206778743637; PMID: 17100612
   PubMed Web of Science ®Google Scholar
• Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, Shoji T, Karahashi K, Hongo M, Fukudo S. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 2004; 53:958 - 64; http://dx.doi.org/10.1136/gut.2003.018911; PMID: 15194643
   PubMed Web of Science ®Google Scholar
• Tillisch K, Labus JS. Advances in imaging the brain-gut axis: functional gastrointestinal disorders. Gastroenterology 2011; 140:407 - 11, e1; http://dx.doi.org/10.1053/j.gastro.2010.12.014; PMID: 21167161
   PubMed Web of Science ®Google Scholar
• Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011; 140:91 - 100; http://dx.doi.org/10.1053/j.gastro.2010.07.053; PMID: 20696168
   PubMed Web of Science ®Google Scholar
• Van Oudenhove L, Coen SJ, Aziz Q. Functional brain imaging of gastrointestinal sensation in health and disease. World J Gastroenterol 2007; 13:3438 - 45; PMID: 17659690
   PubMed Web of Science ®Google Scholar
• Derbyshire SW. A systematic review of neuroimaging data during visceral stimulation. Am J Gastroenterol 2003; 98:12 - 20; http://dx.doi.org/10.1111/j.1572-0241.2003.07168.x; PMID: 12526930
   PubMed Web of Science ®Google Scholar
• Labus JS, Mayer EA, Jarcho J, Kilpatrick LA, Kilkens TO, Evers EA, Backes WH, Brummer RJ, van Nieuwenhoven MA. Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women. Gut 2011; 60:1196 - 203; http://dx.doi.org/10.1136/gut.2010.213447; PMID: 21402618
   PubMed Web of Science ®Google Scholar
• Larsson MB, Tillisch K, Craig AD, Engström M, Labus J, Naliboff B, Lundberg P, Ström M, Mayer EA, Walter SA. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 2012; 142:463 - 72, e3; http://dx.doi.org/10.1053/j.gastro.2011.11.022; PMID: 22108191
   PubMed Web of Science ®Google Scholar
• Tillisch K, Labus J, Nam B, Bueller J, Smith S, Suyenobu B, Siffert J, McKelvy J, Naliboff B, Mayer E. Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study. Aliment Pharmacol Ther 2012; 35:360 - 7; http://dx.doi.org/10.1111/j.1365-2036.2011.04958.x; PMID: 22221140
   PubMed Web of Science ®Google Scholar
• Seminowicz DA, Labus JS, Bueller JA, Tillisch K, Naliboff BD, Bushnell MC, Mayer EA. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology 2010; 139:48 - 57, e2; http://dx.doi.org/10.1053/j.gastro.2010.03.049; PMID: 20347816
   PubMed Web of Science ®Google Scholar
• Chen JY, Blankstein U, Diamant NE, Davis KD. White matter abnormalities in irritable bowel syndrome and relation to individual factors. Brain Res 2011; 1392:121 - 31; http://dx.doi.org/10.1016/j.brainres.2011.03.069; PMID: 21466788
   PubMed Web of Science ®Google Scholar
• Zhou G, Liu P, Wang J, Wen H, Zhu M, Zhao R, von Deneen KM, Zeng F, Liang F, Gong Q, et al. Fractional amplitude of low-frequency fluctuation changes in functional dyspepsia: a resting-state fMRI study. Magn Reson Imaging 2013; 31:996 - 1000; http://dx.doi.org/10.1016/j.mri.2013.03.019; PMID: 23602663
   PubMed Web of Science ®Google Scholar
• Zhou G, Liu P, Zeng F, Yuan K, Yu D, von Deneen KM, Liang F, Qin W, Tian J. Increased interhemispheric resting-state functional connectivity in functional dyspepsia: a pilot study. NMR Biomed 2012; 26:410 - 41; http://dx.doi.org/10.1002/nbm.2878; PMID: 23225275
   PubMed Web of Science ®Google Scholar
• Zeng F, Qin W, Liang F, Liu J, Tang Y, Liu X, Yuan K, Yu S, Song W, Liu M, et al. Abnormal resting brain activity in patients with functional dyspepsia is related to symptom severity. Gastroenterology 2011; 141:499 - 506; http://dx.doi.org/10.1053/j.gastro.2011.05.003; PMID: 21684280
   PubMed Web of Science ®Google Scholar
• Van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Dirix S, Bormans G, Vanderghinste D, Van Laere K, Demyttenaere K, et al. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J Gastroenterol 2010; 105:913 - 24; http://dx.doi.org/10.1038/ajg.2010.39; PMID: 20160711
   PubMed Web of Science ®Google Scholar
• Van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Dirix S, Van Laere K, Bormans G, Vanderghinste D, Demyttenaere K, et al. Regional brain activity in functional dyspepsia: a H(2)(15)O-PET study on the role of gastric sensitivity and abuse history. Gastroenterology 2010; 139:36 - 47; http://dx.doi.org/10.1053/j.gastro.2010.04.015; PMID: 20406641
   PubMed Web of Science ®Google Scholar
• Vandenberghe J, Dupont P, Van Oudenhove L, Bormans G, Demyttenaere K, Fischler B, Geeraerts B, Janssens J, Tack J. Regional cerebral blood flow during gastric balloon distention in functional dyspepsia. Gastroenterology 2007; 132:1684 - 93; http://dx.doi.org/10.1053/j.gastro.2007.03.037; PMID: 17484866
   PubMed Web of Science ®Google Scholar
• Zhou G, Qin W, Zeng F, Liu P, Yang X, von Deneen KM, Gong Q, Liang F, Tian J. White-matter microstructural changes in functional dyspepsia: a diffusion tensor imaging study. Am J Gastroenterol 2013; 108:260 - 9; http://dx.doi.org/10.1038/ajg.2012.405; PMID: 23229422
   PubMed Web of Science ®Google Scholar
• Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013; 14:685 - 90; http://dx.doi.org/10.1038/ni.2608; PMID: 23778796
   PubMed Web of Science ®Google Scholar
• Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90:859 - 904; http://dx.doi.org/10.1152/physrev.00045.2009; PMID: 20664075
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science 2012; 336:1262 - 7; http://dx.doi.org/10.1126/science.1223813; PMID: 22674330
   PubMed Web of Science ®Google Scholar
• Bäckhed F. Programming of host metabolism by the gut microbiota. Ann Nutr Metab 2011; 58:Suppl 2 44 - 52; http://dx.doi.org/10.1159/000328042; PMID: 21846980
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:e280; http://dx.doi.org/10.1371/journal.pbio.0060280; PMID: 19018661
   PubMed Web of Science ®Google Scholar
• Stearns JC, Lynch MD, Senadheera DB, Tenenbaum HC, Goldberg MB, Cvitkovitch DG, Croitoru K, Moreno-Hagelsieb G, Neufeld JD. Bacterial biogeography of the human digestive tract. Sci Rep 2011; 1:170; http://dx.doi.org/10.1038/srep00170; PMID: 22355685
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, et al, MetaHIT Consortium. Enterotypes of the human gut microbiome. Nature 2011; 473:174 - 80; http://dx.doi.org/10.1038/nature09944; PMID: 21508958
   PubMed Web of Science ®Google Scholar
• Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008; 57:1605 - 15; http://dx.doi.org/10.1136/gut.2007.133603; PMID: 18941009
   PubMed Web of Science ®Google Scholar
• Jeffery IB, Claesson MJ, O’Toole PW, Shanahan F. Categorization of the gut microbiota: enterotypes or gradients?. Nat Rev Microbiol 2012; 10:591 - 2; http://dx.doi.org/10.1038/nrmicro2859; PMID: 23066529
   PubMed Web of Science ®Google Scholar
• Hansen CH, Nielsen DS, Kverka M, Zakostelska Z, Klimesova K, Hudcovic T, Tlaskalova-Hogenova H, Hansen AK. Patterns of early gut colonization shape future immune responses of the host. PLoS One 2012; 7:e34043; http://dx.doi.org/10.1371/journal.pone.0034043; PMID: 22479515
   PubMed Web of Science ®Google Scholar
• Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336:489 - 93; http://dx.doi.org/10.1126/science.1219328; PMID: 22442383
   PubMed Web of Science ®Google Scholar
• Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M, Heikenwalder M, Cahenzli J, Velykoredko Y, Balmer ML, Endt K, et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010; 328:1705 - 9; http://dx.doi.org/10.1126/science.1188454; PMID: 20576892
   PubMed Web of Science ®Google Scholar
• Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MA, Geuking MB, Beutler B, Tedder TF, Hardt WD, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325:617 - 20; http://dx.doi.org/10.1126/science.1172747; PMID: 19644121
   PubMed Web of Science ®Google Scholar
• Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, McCoy KD, Macpherson AJ. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011; 34:794 - 806; http://dx.doi.org/10.1016/j.immuni.2011.03.021; PMID: 21596591
   PubMed Web of Science ®Google Scholar
• Benveniste J, Lespinats G, Adam C, Salomon JC. Immunoglobulins in intact, immunized, and contaminated axenic mice: study of serum IgA. J Immunol 1971; 107:1647 - 55; PMID: 4330458
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, Geuking MB, McCoy KD. Homeland security: IgA immunity at the frontiers of the body. Trends Immunol 2012; 33:160 - 7; http://dx.doi.org/10.1016/j.it.2012.02.002; PMID: 22410243
   PubMed Web of Science ®Google Scholar
• Kunii J, Takahashi K, Kasakura K, Tsuda M, Nakano K, Hosono A, Kaminogawa S. Commensal bacteria promote migration of mast cells into the intestine. Immunobiology 2011; 216:692 - 7; http://dx.doi.org/10.1016/j.imbio.2010.10.007; PMID: 21281976
   PubMed Web of Science ®Google Scholar
• Wostmann BS. The germfree animal in nutritional studies. Annu Rev Nutr 1981; 1:257 - 79; http://dx.doi.org/10.1146/annurev.nu.01.070181.001353; PMID: 6764717
   PubMed Web of Science ®Google Scholar
• Rabot S, Membrez M, Bruneau A, Gérard P, Harach T, Moser M, Raymond F, Mansourian R, Chou CJ. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J 2010; 24:4948 - 59; http://dx.doi.org/10.1096/fj.10-164921; PMID: 20724524
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007; 104:979 - 84; http://dx.doi.org/10.1073/pnas.0605374104; PMID: 17210919
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3:213 - 23; http://dx.doi.org/10.1016/j.chom.2008.02.015; PMID: 18407065
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027 - 31; http://dx.doi.org/10.1038/nature05414; PMID: 17183312
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1:ra14; http://dx.doi.org/10.1126/scitranslmed.3000322; PMID: 20368178
   PubMed Web of Science ®Google Scholar
• Gustafsson BE, Midtvedt T, Strandberg K. Effects of microbial contamination on the cecum enlargement of germfree rats. Scand J Gastroenterol 1970; 5:309 - 14; PMID: 5429896
   PubMed Web of Science ®Google Scholar
• Abrams GD, Bishop JE. Effect of the normal microbial flora on gastrointestinal motility. Proc Soc Exp Biol Med 1967; 126:301 - 4; http://dx.doi.org/10.3181/00379727-126-32430; PMID: 6066182
   PubMed Web of Science ®Google Scholar
• Amaral FA, Sachs D, Costa VV, Fagundes CT, Cisalpino D, Cunha TM, Ferreira SH, Cunha FQ, Silva TA, Nicoli JR, et al. Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A 2008; 105:2193 - 7; http://dx.doi.org/10.1073/pnas.0711891105; PMID: 18268332
   PubMed Web of Science ®Google Scholar
• Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG, Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62:159 - 76; http://dx.doi.org/10.1136/gutjnl-2012-302167; PMID: 22730468
   PubMed Web of Science ®Google Scholar
• Jeffery IB, O’Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EM, Simrén M. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61:997 - 1006; http://dx.doi.org/10.1136/gutjnl-2011-301501; PMID: 22180058
   PubMed Web of Science ®Google Scholar
• Carroll IM, Chang YH, Park J, Sartor RB, Ringel Y. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog 2010; 2:19; http://dx.doi.org/10.1186/1757-4749-2-19; PMID: 21143915
   PubMed Web of Science ®Google Scholar
• Chassard C, Dapoigny M, Scott KP, Crouzet L, Del’homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 2012; 35:828 - 38; http://dx.doi.org/10.1111/j.1365-2036.2012.05007.x; PMID: 22315951
   PubMed Web of Science ®Google Scholar
• Codling C, O’Mahony L, Shanahan F, Quigley EM, Marchesi JR. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2010; 55:392 - 7; http://dx.doi.org/10.1007/s10620-009-0934-x; PMID: 19693670
   PubMed Web of Science ®Google Scholar
• Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100:373 - 82; http://dx.doi.org/10.1111/j.1572-0241.2005.40312.x; PMID: 15667495
   PubMed Web of Science ®Google Scholar
• Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH. Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol 2011; 60:817 - 27; http://dx.doi.org/10.1099/jmm.0.028126-0; PMID: 21330412
   PubMed Web of Science ®Google Scholar
• Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009; 29:508 - 18; http://dx.doi.org/10.1111/j.1365-2036.2008.03911.x; PMID: 19053980
   PubMed Web of Science ®Google Scholar
• Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011; 301:G799 - 807; http://dx.doi.org/10.1152/ajpgi.00154.2011; PMID: 21737778
   PubMed Web of Science ®Google Scholar
• Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012; 24:521 - 30, e248; http://dx.doi.org/10.1111/j.1365-2982.2012.01891.x; PMID: 22339879
   PubMed Web of Science ®Google Scholar
• Agostini S, Goubern M, Tondereau V, Salvador-Cartier C, Bezirard V, Lévèque M, Keränen H, Theodorou V, Bourdu-Naturel S, Goupil-Feuillerat N, et al. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol Motil 2012; 24:376 - e172; http://dx.doi.org/10.1111/j.1365-2982.2011.01865.x; PMID: 22272920
   PubMed Web of Science ®Google Scholar
• Kerckhoffs AP, Ben-Amor K, Samsom M, van der Rest ME, de Vogel J, Knol J, Akkermans LM. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol 2011; 60:236 - 45; http://dx.doi.org/10.1099/jmm.0.022848-0; PMID: 20947663
   PubMed Web of Science ®Google Scholar
• Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009; 15:2887 - 92; http://dx.doi.org/10.3748/wjg.15.2887; PMID: 19533811
   PubMed Web of Science ®Google Scholar
• Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol 2010; 10:134; http://dx.doi.org/10.1186/1471-230X-10-134; PMID: 21073731
   PubMed Web of Science ®Google Scholar
• Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011; 141:1782 - 91; http://dx.doi.org/10.1053/j.gastro.2011.06.072; PMID: 21741921
   PubMed Web of Science ®Google Scholar
• Rajilić-Stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141:1792 - 801; http://dx.doi.org/10.1053/j.gastro.2011.07.043; PMID: 21820992
   PubMed Web of Science ®Google Scholar
• Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133:24 - 33; http://dx.doi.org/10.1053/j.gastro.2007.04.005; PMID: 17631127
   PubMed Web of Science ®Google Scholar
• Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Mäkivuokko H, Kajander K, Palva A. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 2009; 9:95; http://dx.doi.org/10.1186/1471-230X-9-95; PMID: 20015409
   PubMed Web of Science ®Google Scholar
• Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L, Palva A. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 2009; 15:5936 - 45; http://dx.doi.org/10.3748/wjg.15.5936; PMID: 20014457
   PubMed Web of Science ®Google Scholar
• Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100:373 - 82; http://dx.doi.org/10.1111/j.1572-0241.2005.40312.x; PMID: 15667495
   PubMed Web of Science ®Google Scholar
• Maukonen J, Satokari R, Mättö J, Söderlund H, Mattila-Sandholm T, Saarela M. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006; 55:625 - 33; http://dx.doi.org/10.1099/jmm.0.46134-0; PMID: 16585652
   PubMed Web of Science ®Google Scholar
• Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982; 5:185 - 94; PMID: 7121297
   PubMed Web of Science ®Google Scholar
• Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004; 10:1802 - 5; PMID: 15188510
   PubMed Web of Science ®Google Scholar
• Parkes GC, Rayment NB, Hudspith BN, Petrovska L, Lomer MC, Brostoff J, Whelan K, Sanderson JD. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 2012; 24:31 - 9; http://dx.doi.org/10.1111/j.1365-2982.2011.01803.x; PMID: 22070725
   PubMed Web of Science ®Google Scholar
• Durbán A, Abellán JJ, Jiménez-Hernández N, Artacho A, Garrigues V, Ortiz V, Ponce J, Latorre A, Moya A. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome. FEMS Microbiol Ecol 2013; 86:581 - 9; http://dx.doi.org/10.1111/1574-6941.12184; PMID: 23889283
   PubMed Web of Science ®Google Scholar
• Durbán A, Abellán JJ, Jiménez-Hernández N, Salgado P, Ponce M, Ponce J, Garrigues V, Latorre A, Moya A. Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome. Environ Microbiol Rep 2012; 4:242 - 7; http://dx.doi.org/10.1111/j.1758-2229.2012.00327.x; PMID: 23757279
   PubMed Web of Science ®Google Scholar
• Mearin F. Postinfectious functional gastrointestinal disorders. J Clin Gastroenterol 2011; 45:Suppl S102 - 5; http://dx.doi.org/10.1097/MCG.0b013e31821fbf58; PMID: 21666422
   PubMed Web of Science ®Google Scholar
• Mearin F. Editorial: From the acute infection to the chronic disorder “Don’t worry it’s just a viral gastroenteritis”. Am J Gastroenterol 2012; 107:900 - 1; http://dx.doi.org/10.1038/ajg.2012.105; PMID: 22664848
   PubMed Web of Science ®Google Scholar
• Ford AC, Thabane M, Collins SM, Moayyedi P, Garg AX, Clark WF, Marshall JK. Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology 2010; 138:1727 - 36, quiz e12; http://dx.doi.org/10.1053/j.gastro.2010.01.043; PMID: 20117111
   PubMed Web of Science ®Google Scholar
• Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26:535 - 44; http://dx.doi.org/10.1111/j.1365-2036.2007.03399.x; PMID: 17661757
   PubMed Web of Science ®Google Scholar
• Marshall JK, Thabane M, Borgaonkar MR, James C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 2007; 5:457 - 60; http://dx.doi.org/10.1016/j.cgh.2006.11.025; PMID: 17289440
   PubMed Web of Science ®Google Scholar
• Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, Lanzini A, San Felice del Benaco Study Investigators. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol 2012; 107:891 - 9; http://dx.doi.org/10.1038/ajg.2012.102; PMID: 22525306
   PubMed Web of Science ®Google Scholar
• Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil 2012; 18:258 - 68; http://dx.doi.org/10.5056/jnm.2012.18.3.258; PMID: 22837873
   PubMed Web of Science ®Google Scholar
• Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2:204; http://dx.doi.org/10.1016/j.chom.2007.08.002; PMID: 18030708
   PubMed Web of Science ®Google Scholar
• Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol 2009; 15:3591 - 6; http://dx.doi.org/10.3748/wjg.15.3591; PMID: 19653335
   PubMed Web of Science ®Google Scholar
• Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis 2013; 4:223 - 31; http://dx.doi.org/10.1177/2040622313496126; PMID: 23997926
   PubMedGoogle Scholar
• Spiegel BM. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastroenterol Hepatol 2011; 9:461 - 9, quiz e59; http://dx.doi.org/10.1016/j.cgh.2011.02.030; PMID: 21397724
   PubMed Web of Science ®Google Scholar
• Ghoshal UC. How to interpret hydrogen breath tests. J Neurogastroenterol Motil 2011; 17:312 - 7; http://dx.doi.org/10.5056/jnm.2011.17.3.312; PMID: 21860825
   PubMed Web of Science ®Google Scholar
• Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008; 53:1443 - 54; http://dx.doi.org/10.1007/s10620-007-0065-1; PMID: 17990113
   PubMed Web of Science ®Google Scholar
• Pimentel M. Evaluating a bacterial hypothesis in IBS using a modification of Koch’s postulates: part 1. Am J Gastroenterol 2010; 105:718 - 21; http://dx.doi.org/10.1038/ajg.2009.678; PMID: 20372119
   PubMed Web of Science ®Google Scholar
• Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y) 2007; 3:112 - 22; PMID: 21960820
   PubMedGoogle Scholar
• Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012; 57:1321 - 9; http://dx.doi.org/10.1007/s10620-012-2033-7; PMID: 22262197
   PubMed Web of Science ®Google Scholar
• Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7:1279 - 86; http://dx.doi.org/10.1016/j.cgh.2009.06.031; PMID: 19602448
   PubMed Web of Science ®Google Scholar
• Chey WD, Maneerattaporn M, Saad R. Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. Gut Liver 2011; 5:253 - 66; http://dx.doi.org/10.5009/gnl.2011.5.3.253; PMID: 21927652
   PubMed Web of Science ®Google Scholar
• Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP, TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364:22 - 32; http://dx.doi.org/10.1056/NEJMoa1004409; PMID: 21208106
   PubMed Web of Science ®Google Scholar
• Pimentel M. An evidence-based treatment algorithm for IBS based on a bacterial/SIBO hypothesis: Part 2. Am J Gastroenterol 2010; 105:1227 - 30; http://dx.doi.org/10.1038/ajg.2010.125; PMID: 20523308
   PubMed Web of Science ®Google Scholar
• Vyas A, Kim SK, Giacomini N, Boothroyd JC, Sapolsky RM. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci U S A 2007; 104:6442 - 7; http://dx.doi.org/10.1073/pnas.0608310104; PMID: 17404235
   PubMed Web of Science ®Google Scholar
• Vyas A, Kim SK, Sapolsky RM. The effects of toxoplasma infection on rodent behavior are dependent on dose of the stimulus. Neuroscience 2007; 148:342 - 8; http://dx.doi.org/10.1016/j.neuroscience.2007.06.021; PMID: 17683872
   PubMed Web of Science ®Google Scholar
• Haroon F, Händel U, Angenstein F, Goldschmidt J, Kreutzmann P, Lison H, Fischer KD, Scheich H, Wetzel W, Schlüter D, et al. Toxoplasma gondii actively inhibits neuronal function in chronically infected mice. PLoS One 2012; 7:e35516; http://dx.doi.org/10.1371/journal.pone.0035516; PMID: 22530040
   PubMed Web of Science ®Google Scholar
• Bass NM. Review article: the current pharmacological therapies for hepatic encephalopathy. Aliment Pharmacol Ther 2007; 25:Suppl 1 23 - 31; http://dx.doi.org/10.1111/j.1746-6342.2006.03218.x; PMID: 17295849
   PubMedGoogle Scholar
• Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362:1071 - 81; http://dx.doi.org/10.1056/NEJMoa0907893; PMID: 20335583
   PubMed Web of Science ®Google Scholar
• Sternbach H, State R. Antibiotics: neuropsychiatric effects and psychotropic interactions. Harv Rev Psychiatry 1997; 5:214 - 26; http://dx.doi.org/10.3109/10673229709000304; PMID: 9427014
   PubMed Web of Science ®Google Scholar
• Mehdi S. Antibiotic-induced psychosis: a link to D-alanine?. Med Hypotheses 2010; 75:676 - 7; http://dx.doi.org/10.1016/j.mehy.2010.07.021; PMID: 20691544
   PubMed Web of Science ®Google Scholar
• Mulle JG, Sharp WG, Cubells JF. The gut microbiome: a new frontier in autism research. Curr Psychiatry Rep 2013; 15:337; http://dx.doi.org/10.1007/s11920-012-0337-0; PMID: 23307560
   PubMed Web of Science ®Google Scholar
• Ledochowski M, Sperner-Unterweger B, Fuchs D. Lactose malabsorption is associated with early signs of mental depression in females: a preliminary report. Dig Dis Sci 1998; 43:2513 - 7; http://dx.doi.org/10.1023/A:1026654820461; PMID: 9824144
   PubMed Web of Science ®Google Scholar
• Ledochowski M, Sperner-Unterweger B, Widner B, Fuchs D. Fructose malabsorption is associated with early signs of mental depression. Eur J Med Res 1998; 3:295 - 8; PMID: 9620891
   PubMedGoogle Scholar
• Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D. Fructose malabsorption is associated with decreased plasma tryptophan. Scand J Gastroenterol 2001; 36:367 - 71; http://dx.doi.org/10.1080/003655201300051135; PMID: 11336160
   PubMed Web of Science ®Google Scholar
• Ledochowski M, Widner B, Sperner-Unterweger B, Propst T, Vogel W, Fuchs D. Carbohydrate malabsorption syndromes and early signs of mental depression in females. Dig Dis Sci 2000; 45:1255 - 9; http://dx.doi.org/10.1023/A:1005527230346; PMID: 10961700
   PubMed Web of Science ®Google Scholar
• Berer K, Krishnamoorthy G. Commensal gut flora and brain autoimmunity: a love or hate affair?. Acta Neuropathol 2012; 123:639 - 51; http://dx.doi.org/10.1007/s00401-012-0949-9; PMID: 22322994
   PubMed Web of Science ®Google Scholar
• Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479:538 - 41; http://dx.doi.org/10.1038/nature10554; PMID: 22031325
   PubMed Web of Science ®Google Scholar
• Ochoa-Repáraz J, Mielcarz DW, Begum-Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 2011; 69:240 - 7; http://dx.doi.org/10.1002/ana.22344; PMID: 21387369
   PubMed Web of Science ®Google Scholar
• Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011; 108:Suppl 1 4615 - 22; http://dx.doi.org/10.1073/pnas.1000082107; PMID: 20660719
   PubMed Web of Science ®Google Scholar
• Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558:263 - 75; http://dx.doi.org/10.1113/jphysiol.2004.063388; PMID: 15133062
   PubMed Web of Science ®Google Scholar
• Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013; 18:666 - 73; http://dx.doi.org/10.1038/mp.2012.77; PMID: 22688187
   PubMed Web of Science ®Google Scholar
• Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011; 108:3047 - 52; http://dx.doi.org/10.1073/pnas.1010529108; PMID: 21282636
   PubMed Web of Science ®Google Scholar
• Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23:255 - 64, e119; http://dx.doi.org/10.1111/j.1365-2982.2010.01620.x; PMID: 21054680
   PubMed Web of Science ®Google Scholar
• Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141:599 - 609, e1-3; http://dx.doi.org/10.1053/j.gastro.2011.04.052; PMID: 21683077
   PubMed Web of Science ®Google Scholar
• Gibson GR, Macfarlane GT, Cummings JH. Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. Gut 1993; 34:437 - 9; http://dx.doi.org/10.1136/gut.34.4.437; PMID: 8491386
   PubMed Web of Science ®Google Scholar
• Matsunami M, Tarui T, Mitani K, Nagasawa K, Fukushima O, Okubo K, Yoshida S, Takemura M, Kawabata A. Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 2009; 58:751 - 61; http://dx.doi.org/10.1136/gut.2007.144543; PMID: 18852258
   PubMed Web of Science ®Google Scholar
• Distrutti E, Cipriani S, Mencarelli A, Renga B, Fiorucci S. Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. PLoS One 2013; 8:e63893; http://dx.doi.org/10.1371/journal.pone.0063893; PMID: 23691109
   PubMedGoogle Scholar
• Shatalin K, Shatalina E, Mironov A, Nudler E. H2S: a universal defense against antibiotics in bacteria. Science 2011; 334:986 - 90; http://dx.doi.org/10.1126/science.1209855; PMID: 22096201
   PubMed Web of Science ®Google Scholar
• Andriulli A, Neri M, Loguercio C, Terreni N, Merla A, Cardarella MP, Federico A, Chilovi F, Milandri GL, De Bona M, et al. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study. J Clin Gastroenterol 2008; 42:Suppl 3 Pt 2 S218 - 23; http://dx.doi.org/10.1097/MCG.0b013e31817fadd6; PMID: 18685503
   PubMed Web of Science ®Google Scholar
• Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005; 147:197 - 201; http://dx.doi.org/10.1016/j.jpeds.2005.05.015; PMID: 16126049
   PubMed Web of Science ®Google Scholar
• Cui S, Hu Y. Multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Int J Clin Exp Med 2012; 5:238 - 44; PMID: 22837798
   PubMedGoogle Scholar
• Diop L, Guillou S, Durand H. Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial. Nutr Res 2008; 28:1 - 5; http://dx.doi.org/10.1016/j.nutres.2007.10.001; PMID: 19083380
   PubMed Web of Science ®Google Scholar
• Enck P, Zimmermann K, Menke G, Klosterhalfen S. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo. Z Gastroenterol 2009; 47:209 - 14; http://dx.doi.org/10.1055/s-2008-1027702; PMID: 19197823
   PubMed Web of Science ®Google Scholar
• Enck P, Zimmermann K, Menke G, Müller-Lissner S, Martens U, Klosterhalfen S. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome--a randomized controlled trial with primary care physicians. Neurogastroenterol Motil 2008; 20:1103 - 9; http://dx.doi.org/10.1111/j.1365-2982.2008.01156.x; PMID: 18565142
   PubMed Web of Science ®Google Scholar
• Francavilla R, Miniello V, Magistà AM, De Canio A, Bucci N, Gagliardi F, Lionetti E, Castellaneta S, Polimeno L, Peccarisi L, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 2010; 126:e1445 - 52; http://dx.doi.org/10.1542/peds.2010-0467; PMID: 21078735
   PubMed Web of Science ®Google Scholar
• Gawrońska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 2007; 25:177 - 84; http://dx.doi.org/10.1111/j.1365-2036.2006.03175.x; PMID: 17229242
   PubMed Web of Science ®Google Scholar
• Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33:1123 - 32; http://dx.doi.org/10.1111/j.1365-2036.2011.04633.x; PMID: 21418261
   PubMed Web of Science ®Google Scholar
• Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 2011; 33:1302 - 10; http://dx.doi.org/10.1111/j.1365-2036.2011.04665.x; PMID: 21507030
   PubMed Web of Science ®Google Scholar
• Hun L. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgrad Med 2009; 121:119 - 24; http://dx.doi.org/10.3810/pgm.2009.03.1984; PMID: 19332970
   PubMed Web of Science ®Google Scholar
• Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001; 13:1143 - 7; http://dx.doi.org/10.1097/00042737-200110000-00004; PMID: 11711768
   PubMed Web of Science ®Google Scholar
• O’Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O’Sullivan GC, Kiely B, Collins JK, Shanahan F, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541 - 51; http://dx.doi.org/10.1053/j.gastro.2004.11.050; PMID: 15765388
   PubMed Web of Science ®Google Scholar
• Sinn DH, Song JH, Kim HJ, Lee JH, Son HJ, Chang DK, Kim YH, Kim JJ, Rhee JC, Rhee PL. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci 2008; 53:2714 - 8; http://dx.doi.org/10.1007/s10620-007-0196-4; PMID: 18274900
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O’Mahony L, Kiely B, Shanahan F, Quigley EM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006; 101:1581 - 90; http://dx.doi.org/10.1111/j.1572-0241.2006.00734.x; PMID: 16863564
   PubMed Web of Science ®Google Scholar
• Williams EA, Stimpson J, Wang D, Plummer S, Garaiova I, Barker ME, Corfe BM. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther 2009; 29:97 - 103; http://dx.doi.org/10.1111/j.1365-2036.2008.03848.x; PMID: 18785988
   PubMed Web of Science ®Google Scholar
• Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, et al. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol 2014; 29:52 - 9; http://dx.doi.org/10.1111/jgh.12322; PMID: 23829297
   PubMed Web of Science ®Google Scholar
• Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, et al. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol 2012; 46:220 - 7; http://dx.doi.org/10.1097/MCG.0b013e31823712b1; PMID: 22157240
   PubMed Web of Science ®Google Scholar
• Michail S, Kenche H. Gut microbiota is not modified by Randomized, Double-blind, Placebo-controlled Trial of VSL#3 in Diarrhea-predominant Irritable Bowel Syndrome. Probiotics Antimicrob Proteins 2011; 3:1 - 7; http://dx.doi.org/10.1007/s12602-010-9059-y; PMID: 22247743
   PubMed Web of Science ®Google Scholar
• Guandalini S, Magazzù G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr 2010; 51:24 - 30; http://dx.doi.org/10.1097/MPG.0b013e3181ca4d95; PMID: 20453678
   PubMed Web of Science ®Google Scholar
• Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 2007; 61:355 - 61; http://dx.doi.org/10.1038/sj.ejcn.1602546; PMID: 17151594
   PubMed Web of Science ®Google Scholar
• Messaoudi M, Violle N, Bisson JF, Desor D, Javelot H, Rougeot C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011; 2:256 - 61; http://dx.doi.org/10.4161/gmic.2.4.16108; PMID: 21983070
   PubMed Web of Science ®Google Scholar
• Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson JF, Rougeot C, Pichelin M, Cazaubiel M, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011; 105:755 - 64; http://dx.doi.org/10.1017/S0007114510004319; PMID: 20974015
   PubMed Web of Science ®Google Scholar
• Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain-Raspaud S, Trotin B, Naliboff B, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013; 144:1394 - 401, e1-4; http://dx.doi.org/10.1053/j.gastro.2013.02.043; PMID: 23474283
   PubMed Web of Science ®Google Scholar
• Verdú EF, Bercík P, Bergonzelli GE, Huang XX, Blennerhasset P, Rochat F, Fiaux M, Mansourian R, Corthésy-Theulaz I, Collins SM. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology 2004; 127:826 - 37; http://dx.doi.org/10.1053/j.gastro.2004.06.007; PMID: 15362038
   PubMed Web of Science ®Google Scholar
• Johnson AC, Greenwood-Van Meerveld B, McRorie J. Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat. Dig Dis Sci 2011; 56:3179 - 86; http://dx.doi.org/10.1007/s10620-011-1730-y; PMID: 21562785
   PubMed Web of Science ®Google Scholar
• McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 2010; 22:1029 - 35, e268; http://dx.doi.org/10.1111/j.1365-2982.2010.01520.x; PMID: 20518856
   PubMed Web of Science ®Google Scholar
• Dai C, Guandalini S, Zhao DH, Jiang M. Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function. Mol Cell Biochem 2012; 362:43 - 53; http://dx.doi.org/10.1007/s11010-011-1126-5; PMID: 22020749
   PubMed Web of Science ®Google Scholar
• Verdú EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F, Collins SM. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006; 55:182 - 90; http://dx.doi.org/10.1136/gut.2005.066100; PMID: 16105890
   PubMed Web of Science ®Google Scholar
• Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13:35 - 7; http://dx.doi.org/10.1038/nm1521; PMID: 17159985
   PubMed Web of Science ®Google Scholar
• Eutamene H, Lamine F, Chabo C, Theodorou V, Rochat F, Bergonzelli GE, Corthésy-Theulaz I, Fioramonti J, Bueno L. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr 2007; 137:1901 - 7; PMID: 17634262
   PubMed Web of Science ®Google Scholar
• Barreau F, Ferrier L, Fioramonti J, Bueno L. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatr Res 2007; 62:240 - 5; http://dx.doi.org/10.1203/PDR.0b013e3180db2949; PMID: 17622962
   PubMed Web of Science ®Google Scholar
• Gareau MG, Jury J, Perdue MH. Neonatal maternal separation of rat pups results in abnormal cholinergic regulation of epithelial permeability. Am J Physiol Gastrointest Liver Physiol 2007; 293:G198 - 203; http://dx.doi.org/10.1152/ajpgi.00392.2006; PMID: 17510196
   PubMedGoogle Scholar
• O’Mahony SM, Hyland NP, Dinan TG, Cryan JF. Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl) 2011; 214:71 - 88; http://dx.doi.org/10.1007/s00213-010-2010-9; PMID: 20886335
   PubMed Web of Science ®Google Scholar
• Lippmann M, Bress A, Nemeroff CB, Plotsky PM, Monteggia LM. Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci 2007; 25:3091 - 8; http://dx.doi.org/10.1111/j.1460-9568.2007.05522.x; PMID: 17561822
   PubMed Web of Science ®Google Scholar
• Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog Brain Res 2000; 122:81 - 103; http://dx.doi.org/10.1016/S0079-6123(08)62132-9; PMID: 10737052
   PubMed Web of Science ®Google Scholar
• Li M, Xue X, Shao S, Shao F, Wang W. Cognitive, emotional and neurochemical effects of repeated maternal separation in adolescent rats. Brain Res 2013; 1518:82 - 90; http://dx.doi.org/10.1016/j.brainres.2013.04.026; PMID: 23623774
   PubMed Web of Science ®Google Scholar
• Söderholm JD, Yates DA, Gareau MG, Yang PC, MacQueen G, Perdue MH. Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am J Physiol Gastrointest Liver Physiol 2002; 283:G1257 - 63; PMID: 12388189
   PubMed Web of Science ®Google Scholar
• Varghese AK, Verdú EF, Bercik P, Khan WI, Blennerhassett PA, Szechtman H, Collins SM. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology 2006; 130:1743 - 53; http://dx.doi.org/10.1053/j.gastro.2006.02.007; PMID: 16697738
   PubMed Web of Science ®Google Scholar
• Barreau F, Ferrier L, Fioramonti J, Bueno L. Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats. Gut 2004; 53:501 - 6; http://dx.doi.org/10.1136/gut.2003.024174; PMID: 15016743
   PubMed Web of Science ®Google Scholar
• Moloney RD, O’Leary OF, Felice D, Bettler B, Dinan TG, Cryan JF. Early-life stress induces visceral hypersensitivity in mice. Neurosci Lett 2012; 512:99 - 102; http://dx.doi.org/10.1016/j.neulet.2012.01.066; PMID: 22326388
   PubMed Web of Science ®Google Scholar
• O’Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF, Dinan TG. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009; 65:263 - 7; http://dx.doi.org/10.1016/j.biopsych.2008.06.026; PMID: 18723164
   PubMed Web of Science ®Google Scholar
• Oines E, Murison R, Mrdalj J, Grønli J, Milde AM. Neonatal maternal separation in male rats increases intestinal permeability and affects behavior after chronic social stress. Physiol Behav 2012; 105:1058 - 66; http://dx.doi.org/10.1016/j.physbeh.2011.11.024; PMID: 22155491
   PubMedGoogle Scholar
• Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010; 170:1179 - 88; http://dx.doi.org/10.1016/j.neuroscience.2010.08.005; PMID: 20696216
   PubMed Web of Science ®Google Scholar
• Gareau MG, Jury J, MacQueen G, Sherman PM, Perdue MH. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007; 56:1522 - 8; http://dx.doi.org/10.1136/gut.2006.117176; PMID: 17339238
   PubMed Web of Science ®Google Scholar
• Eutamene H, Bueno L. Role of probiotics in correcting abnormalities of colonic flora induced by stress. Gut 2007; 56:1495 - 7; http://dx.doi.org/10.1136/gut.2007.124040; PMID: 17938427
   PubMed Web of Science ®Google Scholar
• Giada De Palma PB. Jun Lu,Amber J.Park,Vivek Philip,Manuel A.Silva,Elena F.Verdu,Stephen M.Collins,Premysl Bercik. Su1990 The Role of Microbiota in the Maternal Separation Model of Depression. Gastroenterology 2012; 142:pS554
   Google Scholar
• Bercík P, De Giorgio R, Blennerhassett P, Verdú EF, Barbara G, Collins SM. Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology 2002; 123:1205 - 15; http://dx.doi.org/10.1053/gast.2002.36024; PMID: 12360482
   PubMed Web of Science ®Google Scholar
• Bercik P, Verdú EF, Foster JA, Lu J, Scharringa A, Kean I, Wang L, Blennerhassett P, Collins SM. Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am J Physiol Regul Integr Comp Physiol 2009; 296:R587 - 94; http://dx.doi.org/10.1152/ajpregu.90752.2008; PMID: 19129375
   PubMed Web of Science ®Google Scholar
• Bailey MT, Dowd SE, Parry NM, Galley JD, Schauer DB, Lyte M. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun 2010; 78:1509 - 19; http://dx.doi.org/10.1128/IAI.00862-09; PMID: 20145094
   PubMed Web of Science ®Google Scholar
• Ibeakanma C, Miranda-Morales M, Richards M, Bautista-Cruz F, Martin N, Hurlbut D, Vanner S. Citrobacter rodentium colitis evokes post-infectious hyperexcitability of mouse nociceptive colonic dorsal root ganglion neurons. J Physiol 2009; 587:3505 - 21; http://dx.doi.org/10.1113/jphysiol.2009.169110; PMID: 19470777
   PubMed Web of Science ®Google Scholar
• Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. Citrobacter rodentium of mice and man. Cell Microbiol 2005; 7:1697 - 706; http://dx.doi.org/10.1111/j.1462-5822.2005.00625.x; PMID: 16309456
   PubMed Web of Science ®Google Scholar
• Mackos AR, Eubank TD, Parry NM, Bailey MT. Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection. Infect Immun 2013; 81:3253 - 63; http://dx.doi.org/10.1128/IAI.00278-13; PMID: 23798531
   PubMed Web of Science ®Google Scholar
• Ibeakanma C, Ochoa-Cortes F, Miranda-Morales M, McDonald T, Spreadbury I, Cenac N, Cattaruzza F, Hurlbut D, Vanner S, Bunnett N, et al. Brain-gut interactions increase peripheral nociceptive signaling in mice with postinfectious irritable bowel syndrome. Gastroenterology 2011; 141:2098 - 108, e5; http://dx.doi.org/10.1053/j.gastro.2011.08.006; PMID: 21856270
   PubMed Web of Science ®Google Scholar
• Lyte M, Li W, Opitz N, Gaykema RP, Goehler LE. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 2006; 89:350 - 7; http://dx.doi.org/10.1016/j.physbeh.2006.06.019; PMID: 16887154
   PubMed Web of Science ®Google Scholar
• Riddle MS, Gutierrez RL, Verdu EF, Porter CK. The chronic gastrointestinal consequences associated with campylobacter. Curr Gastroenterol Rep 2012; 14:395 - 405; http://dx.doi.org/10.1007/s11894-012-0278-0; PMID: 22864805
   PubMedGoogle Scholar
• Lyte M, Varcoe JJ, Bailey MT. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav 1998; 65:63 - 8; http://dx.doi.org/10.1016/S0031-9384(98)00145-0; PMID: 9811366
   PubMed Web of Science ®Google Scholar
• Gaykema RP, Goehler LE, Lyte M. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav Immun 2004; 18:238 - 45; http://dx.doi.org/10.1016/j.bbi.2003.08.002; PMID: 15050651
   PubMed Web of Science ®Google Scholar
• Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N, Lyte M. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 2005; 19:334 - 44; http://dx.doi.org/10.1016/j.bbi.2004.09.002; PMID: 15944073
   PubMed Web of Science ®Google Scholar
• Goehler LE, Park SM, Opitz N, Lyte M, Gaykema RP. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun 2008; 22:354 - 66; http://dx.doi.org/10.1016/j.bbi.2007.08.009; PMID: 17920243
   PubMed Web of Science ®Google Scholar
• Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011; 23:1132 - 9; http://dx.doi.org/10.1111/j.1365-2982.2011.01796.x; PMID: 21988661
   PubMed Web of Science ®Google Scholar
• Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010; 139:2102 - 12, e1; http://dx.doi.org/10.1053/j.gastro.2010.06.063; PMID: 20600016
   PubMed Web of Science ®Google Scholar
• Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, Macqueen G, Sherman PM. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011; 60:307 - 17; http://dx.doi.org/10.1136/gut.2009.202515; PMID: 20966022
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59:325 - 32; http://dx.doi.org/10.1136/gut.2008.167270; PMID: 19091823
   PubMed Web of Science ®Google Scholar
• Ortiz-Lucas M, Tobías A, Saz P, Sebastián JJ. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. Rev Esp Enferm Dig 2013; 105:19 - 36; http://dx.doi.org/10.4321/S1130-01082013000100005; PMID: 23548007
   PubMed Web of Science ®Google Scholar
• Whelan K, Quigley EM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013; 29:184 - 9; http://dx.doi.org/10.1097/MOG.0b013e32835d7bba; PMID: 23286925
   PubMed Web of Science ®Google Scholar